LegoChem Biosciences, Inc.
KOSDAQ 141080.KQ
LegoChem Biosciences, Inc. Market Capitalization on January 14, 2025: USD 2.88 B
-
LegoChem Biosciences, Inc. 52-week high Market Capitalization is USD 4.49 B on November 12, 2024, which is 55.83% above the current Market Capitalization.
-
LegoChem Biosciences, Inc. 52-week low Market Capitalization is USD 1.26 B on February 05, 2024, which is -56.21% below the current Market Capitalization.
-
LegoChem Biosciences, Inc. average Market Capitalization for the last 52 weeks is USD 2.21 B.
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
| CEO | Mr. Yong Zu Kim Ph.D. |
| IPO Date | May 10, 2013 |
| Location | |
| Headquarters | 10, Gukjegwahak 10-ro |
| Employees | 157 |
| Sector | Health Care |
| Industries | |
LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email